BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm
A few genetic variants are implicated in the development of blepharospasm (BSP). The precise role of the rs6265 on the brain-derived neurotrophic factor (BDNF) gene on BSP remains controversial. The effect of rs6265 on BSP was evaluated. 206 patients with BSP and 206 healthy controls were recruited and genotyped for the rs6265. We also performed a meta-analysis, by pooling our results with those from previous studies. A significant effect of rs6265 on the risk of BSP was found in the dominant model of inheritance [odds ratio (OR) (95% confidence interval (CI) 1.52 (1.01–2.29), p = 0.044]. Mutational load analysis of rs6265 in the risk of BSP using the ORG revealed that higher load of the “A” allele of rs6265 denotes higher probability of a subject to develop BSP (ORG 1.48; 95% CI 1.00–2.19). Finally, pooled results from the meta-analysis revealed that the rs6265 is associated with an increased risk of BSP in the dominant model [OR 1.26; 95% CI 1.02–1.55, pz = 0.03]. Also, higher load of the “A” allele of rs6265 denotes higher probability of a subject to develop BSP (ORG 1.26; 95% CI 1.04–1.53). The present study provides additional evidence to the existing knowledge concerning the contribution of the rs6265 BDNF on the risk of developing BSP. While the pathophysiology and genetic susceptibility in BSP and focal dystonia are only partially understood, it seems that BDNF and rs6265 may constitute one essential risk factor that is heavily involved.
KeywordsBDNF Blepharospasm Focal dystonia Polymorphism SNP
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent was obtained from all individual participants included in the study.
- Anastasia, A., & Hempstead, B. L. (2014). BDNF function in health and disease (Poster). Nature Reviews Neuroscience, 15(2). https://www.nature.com/nrn/posters/bdnf/index.html.
- Cattaneo, A., Cattane, N., Begni, V., Pariante, C. M., & Riva, M. A. (2016). The human BDNF gene: Peripheral gene expression and protein levels as biomarkers for psychiatric disorders. Translational Psychiatry, 6(11), e958. https://doi.org/10.1038/tp.2016.214.CrossRefPubMedCentralPubMedGoogle Scholar
- Chen, Y., Song, W., Yang, J., Chen, K., Huang, R., Zhao, B., et al. (2013). Association of the Val66Met polymorphism of the BDNF gene with primary cranial-cervical dystonia patients from South-west China. Parkinsonism & Related Disorders, 19(11), 1043–1045. https://doi.org/10.1016/j.parkreldis.2013.06.004.CrossRefGoogle Scholar
- Dardiotis, E., Siokas, V., Sokratous, M., Tsouris, Z., Michalopoulou, A., Andravizou, A., et al. (2018). Genetic polymorphisms in amyotrophic lateral sclerosis: Evidence for implication in detoxification pathways of environmental toxicants. Environment International, 116, 122–135. https://doi.org/10.1016/j.envint.2018.04.008.CrossRefPubMedGoogle Scholar
- Defazio, G., Hallett, M., Jinnah, H. A., Stebbins, G. T., Gigante, A. F., Ferrazzano, G., et al. (2015). Development and validation of a clinical scale for rating the severity of blepharospasm. Movement Disorders, 30(4), 525–530. https://doi.org/10.1002/mds.26156.CrossRefPubMedCentralPubMedGoogle Scholar
- Gomez-Garre, P., Huertas-Fernandez, I., Caceres-Redondo, M. T., Alonso-Canovas, A., Bernal-Bernal, I., Blanco-Ollero, A., et al. (2014). BDNF Val66Met polymorphism in primary adult-onset dystonia: A case-control study and meta-analysis. Movement Disorders, 29(8), 1083–1086. https://doi.org/10.1002/mds.25938.CrossRefPubMedGoogle Scholar
- Liu, M. E., Huang, C. C., Chen, M. H., Yang, A. C., Tu, P. C., Yeh, H. L., et al. (2014). Effect of the BDNF Val66Met polymorphism on regional gray matter volumes and cognitive function in the Chinese population. Neuromolecular Medicine, 16(1), 127–136. https://doi.org/10.1007/s12017-013-8265-7.CrossRefPubMedGoogle Scholar
- Ma, L., Chen, Y., Wang, L., Yang, Y., Cheng, F., Tian, Y., et al. (2013). Brain-derived neurotrophic factor Val66Met polymorphism is not associated with primary dystonia in a Chinese population. Neuroscience Letters, 533, 100–103. https://doi.org/10.1016/j.neulet.2012.11.037.CrossRefPubMedGoogle Scholar
- Martino, D., Muglia, M., Abbruzzese, G., Berardelli, A., Girlanda, P., Liguori, M., et al. (2009). Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia. European Journal of Neurology, 16(8), 949–952. https://doi.org/10.1111/j.1468-1331.2009.02633.x.CrossRefPubMedGoogle Scholar
- Mok, K. Y., Schneider, S. A., Trabzuni, D., Stamelou, M., Edwards, M., Kasperaviciute, D., et al. (2014). Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel. Movement Disorders, 29(2), 245–251. https://doi.org/10.1002/mds.25732.CrossRefPubMedGoogle Scholar
- Newman, J. R., Sutherland, G. T., Boyle, R. S., Limberg, N., Blum, S., O’Sullivan, J. D., et al. (2012). Common polymorphisms in dystonia-linked genes and susceptibility to the sporadic primary dystonias. Parkinsonism & Related Disorders, 18(4), 351–357. https://doi.org/10.1016/j.parkreldis.2011.11.024.CrossRefGoogle Scholar
- Quartarone, A., Morgante, F., Sant’angelo, A., Rizzo, V., Bagnato, S., Terranova, C., et al. (2008). Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia. Journal of Neurology, Neurosurgery & Psychiatry, 79(9), 985–990. https://doi.org/10.1136/jnnp.2007.121632.CrossRefGoogle Scholar
- Siokas, V., Dardiotis, E., Sokolakis, T., Kotoula, M., Tachmitzi, S. V., Chatzoulis, D. Z., et al. (2017a). Plasminogen activator inhibitor type-1 tag single-nucleotide polymorphisms in patients with diabetes mellitus type 2 and diabetic retinopathy. Current Eye Research, 42(7), 1048–1053. https://doi.org/10.1080/02713683.2016.1276197.CrossRefPubMedGoogle Scholar
- Svetel, M. V., Djuric, G., Novakovic, I., Dobricic, V., Stefanova, E., Kresojevic, N., et al. (2013). A common polymorphism in the brain-derived neurotrophic factor gene in patients with adult-onset primary focal and segmental dystonia. Acta Neurologica Belgica, 113(3), 243–245. https://doi.org/10.1007/s13760-013-0183-9.CrossRefPubMedGoogle Scholar
- Theuns, J., Verstraeten, A., Sleegers, K., Wauters, E., Gijselinck, I., Smolders, S., et al. (2014). Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease. Neurology, 83(21), 1906–1913. https://doi.org/10.1212/wnl.0000000000001012.CrossRefPubMedCentralPubMedGoogle Scholar